![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 27, 24353-24360, July 5, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and
on Cyclin
D1 Gene Expression*
,
¶
,
,
¶**
From the Induction of cyclin D1 gene transcription by
estrogen receptor
Department of Medicine, University of
California, San Francisco, California 94112-1640, the
§ Albert Einstein Cancer Center, Department of Developmental
and Molecular Biology, Albert Einstein College of Medicine, Bronx,
New York 10461, and the ¶ Metabolic Research Unit, University of
California, San Francisco, California 94143
(ER
) plays an important role in
estrogen-mediated proliferation. There is no classical estrogen
response element in the cyclin D1 promoter, and induction by ER
has
been mapped to an alternative response element, a cyclic AMP-response
element at
57, with possible participation of an activating protein-1
site at
954. The action of ER
at the cyclin D1 promoter is
unknown, although evidence suggests that ER
may inhibit the
proliferative action of ER
. We examined the response of cyclin D1
promoter constructs by luciferase assay and the response of the
endogenous protein by Western blot in HeLa cells transiently expressing
ER
, ER
K206A (a derivative that is superactive at alternative
response elements), or ER
. In each case, ER activation at the cyclin
D1 promoter is mediated by both the cyclic AMP-response element and the
activating protein-1 site, which play partly redundant roles. The
activation by ER
occurs only with antiestrogens. Estrogens, which
activate cyclin D1 gene expression with ER
, inhibit expression with
ER
. Strikingly, the presence of ER
completely inhibits cyclin D1
gene activation by estrogen and ER
or even by estrogen and the
superactive ER
K206A. The observation of the opposing action and
dominance of ER
over ER
in activation of cyclin D1 gene
expression has implications for the postulated role of ER
as a
modulator of the proliferative effects of estrogen.
Present address: Depts. of Pathology and Biochemistry and
Molecular Genetics, University of Virginia, Charlottesville, VA 22908-0214.
**
Consultant, Director, and holder of significant financial interests
in KaroBio AB, a Swedish company that develops pharmaceuticals that
target nuclear receptors. To whom correspondence should be addressed:
Dept. of Medicine, 2200 Post St., Rm. C442, University of California,
San Francisco, CA 94112-1640. Tel.: 415-476-6790; Fax: 415-885-7724;
E-mail: kushner@itsa.ucsf.edu.
This article has been cited by other articles:
![]() |
E. C. Chang, T. H. Charn, S.-H. Park, W. G. Helferich, B. Komm, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Estrogen Receptors {alpha} and {beta} as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding Mol. Endocrinol., May 1, 2008; 22(5): 1032 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Teng, Z.-Y. Wang, D. F Jarrard, and D. E Bjorling Roles of estrogen receptor {alpha} and {beta} in modulating urothelial cell proliferation Endocr. Relat. Cancer, March 1, 2008; 15(1): 351 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Renoir, C. Bouclier, A. Seguin, V. Marsaud, and B. Sola Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells J. Mol. Endocrinol., March 1, 2008; 40(3): 101 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis Endocrinology, March 1, 2008; 149(3): 1190 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Damdimopoulos, G. Spyrou, and J.-A. Gustafsson Ligands Differentially Modify the Nuclear Mobility of Estrogen Receptors {alpha} and Endocrinology, January 1, 2008; 149(1): 339 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohtani, A. Garcia, A. B. Rogers, Z. Ge, N. S. Taylor, S. Xu, K. Watanabe, R. P. Marini, M. T. Whary, T. C. Wang, et al. Protective role of 17 -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice Carcinogenesis, December 1, 2007; 28(12): 2597 - 2604. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fernando, J. S. Foster, A. Bible, A. Strom, R. G. Pestell, M. Rao, A. Saxton, S. J. Baek, K. Yamaguchi, R. Donnell, et al. Breast Cancer Cell Proliferation Is Inhibited by BAD: REGULATION OF CYCLIN D1 J. Biol. Chem., September 28, 2007; 282(39): 28864 - 28873. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fiskus, Y. Ren, A. Mohapatra, P. Bali, A. Mandawat, R. Rao, B. Herger, Y. Yang, P. Atadja, J. Wu, et al. Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-{alpha} Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90 Clin. Cancer Res., August 15, 2007; 13(16): 4882 - 4890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nozoe, T. Oyama, M. Takenoyama, T. Hanagiri, K. Sugio, and K. Yasumoto Significance of Immunohistochemical Expression of Estrogen Receptors {alpha} and {beta} in Squamous Cell Carcinoma of the Esophagus Clin. Cancer Res., July 15, 2007; 13(14): 4046 - 4050. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al. Estrogen Receptors: How Do They Signal and What Are Their Targets Physiol Rev, July 1, 2007; 87(3): 905 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Connor, M. J. Meyer, R. W. Li, M. E. Van Amburgh, Y. R. Boisclair, and A. V. Capuco Regulation of Gene Expression in the Bovine Mammary Gland by Ovarian Steroids J Dairy Sci, June 1, 2007; 90(13_suppl): E55 - E65. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Cho, S. H. Javid, A. M. Carothers, M. Redston, and M. M. Bertagnolli Estrogen Receptors {alpha} and {beta} Are Inhibitory Modifiers of Apc-Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice Cancer Res., March 1, 2007; 67(5): 2366 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. D. Krom, N. M.M. Pires, J. W. Jukema, M. R. de Vries, R. R. Frants, L. M. Havekes, K. W. van Dijk, and P. H.A. Quax Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists Cardiovasc Res, January 1, 2007; 73(1): 217 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Chang, J. Frasor, B. Komm, and B. S. Katzenellenbogen Impact of Estrogen Receptor {beta} on Gene Networks Regulated by Estrogen Receptor {alpha} in Breast Cancer Cells Endocrinology, October 1, 2006; 147(10): 4831 - 4842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eeckhoute, J. S. Carroll, T. R. Geistlinger, M. I. Torres-Arzayus, and M. Brown A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer Genes & Dev., September 15, 2006; 20(18): 2513 - 2526. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Titolo, F. Cai, and D. D. Belsham Coordinate Regulation of Neuropeptide Y and Agouti-Related Peptide Gene Expression by Estrogen Depends on the Ratio of Estrogen Receptor (ER) {alpha} to ER{beta} in Clonal Hypothalamic Neurons Mol. Endocrinol., September 1, 2006; 20(9): 2080 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Garcia-Pedrero, E. Kiskinis, M. G. Parker, and B. Belandia The SWI/SNF Chromatin Remodeling Subunit BAF57 Is a Critical Regulator of Estrogen Receptor Function in Breast Cancer Cells J. Biol. Chem., August 11, 2006; 281(32): 22656 - 22664. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Riggins, K. S. Thomas, H. Q. Ta, J. Wen, R. J. Davis, N. R. Schuh, S. S. Donelan, K. A. Owen, M. A. Gibson, M. A. Shupnik, et al. Physical and Functional Interactions between Cas and c-Src Induce Tamoxifen Resistance of Breast Cancer Cells through Pathways Involving Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 5b. Cancer Res., July 15, 2006; 66(14): 7007 - 7015. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haeger, M. E. Andres, M. I. Forray, C. Daza, S. Araneda, and K. Gysling Estrogen receptors alpha and beta differentially regulate the transcriptional activity of the Urocortin gene. J. Neurosci., May 3, 2006; 26(18): 4908 - 4916. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Almeida, L. Han, C. A. O'Brien, S. Kousteni, and S. C. Manolagas Classical Genotropic Versus Kinase-Initiated Regulation of Gene Transcription by the Estrogen Receptor {alpha} Endocrinology, April 1, 2006; 147(4): 1986 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Matthews, B. Wihlen, M. Tujague, J. Wan, A. Strom, and J.-A. Gustafsson Estrogen Receptor (ER) {beta} Modulates ER{alpha}-Mediated Transcriptional Activation by Altering the Recruitment of c-Fos and c-Jun to Estrogen-Responsive Promoters Mol. Endocrinol., March 1, 2006; 20(3): 534 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Penot, C. Le Peron, Y. Merot, E. Grimaud-Fanouillere, F. Ferriere, N. Boujrad, O. Kah, C. Saligaut, B. Ducouret, R. Metivier, et al. The Human Estrogen Receptor-{alpha} Isoform hER{alpha}46 Antagonizes the Proliferative Influence of hER{alpha}66 in MCF7 Breast Cancer Cells Endocrinology, December 1, 2005; 146(12): 5474 - 5484. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Imamov, G.-J. Shim, M. Warner, and J.-A. Gustafsson Estrogen Receptor beta in Health and Disease Biol Reprod, November 1, 2005; 73(5): 866 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, R. Schiff, G. Arpino, C. K. Osborne, and A. V. Lee Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy J. Clin. Oncol., October 20, 2005; 23(30): 7721 - 7735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawai, A. Ishii, K. Washiya, T. Konno, H. Kon, C. Yamaya, I. Ono, Y. Minamiya, and J. Ogawa Estrogen Receptor {alpha} and {beta} are Prognostic Factors in Non-Small Cell Lung Cancer Clin. Cancer Res., July 15, 2005; 11(14): 5084 - 5089. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Koehler, L. A. Helguero, L.-A. Haldosen, M. Warner, and J.-A. Gustafsson Reflections on the Discovery and Significance of Estrogen Receptor {beta} Endocr. Rev., May 1, 2005; 26(3): 465 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Lee, N. Nadiminty, X. X. Wu, W. Lou, Y. Dong, C. Ip, S. A. Onate, and A. C. Gao Selenium Disrupts Estrogen Signaling by Altering Estrogen Receptor Expression and Ligand Binding in Human Breast Cancer Cells Cancer Res., April 15, 2005; 65(8): 3487 - 3492. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bjornstrom and M. Sjoberg Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes Mol. Endocrinol., April 1, 2005; 19(4): 833 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qiu, L. Shan, M. Yu, and E. G. Snyderwine Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, April 1, 2005; 26(4): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Sutherland, M. Schuliga, T. Harris, B. L. Eckhardt, R. L. Anderson, L. Quan, and A. G. Stewart 2-Methoxyestradiol Is an Estrogen Receptor Agonist That Supports Tumor Growth in Murine Xenograft Models of Breast Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1722 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Hershberger, A. C. Vasquez, B. Kanterewicz, S. Land, J. M. Siegfried, and M. Nichols Regulation of Endogenous Gene Expression in Human Non-Small Cell Lung Cancer Cells by Estrogen Receptor Ligands Cancer Res., February 15, 2005; 65(4): 1598 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S Lewis, T J Thomas, R. G Pestell, C. Albanese, M. A Gallo, and T. Thomas Differential effects of 16{alpha}-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells J. Mol. Endocrinol., February 1, 2005; 34(1): 91 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. DeNardo, H.-T. Kim, S. Hilsenbeck, V. Cuba, A. Tsimelzon, and P. H. Brown Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes Mol. Endocrinol., February 1, 2005; 19(2): 362 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bryant, A. E. Snowhite, L. W. Rice, and M. A. Shupnik The Estrogen Receptor (ER){alpha} Variant {Delta}5 Exhibits Dominant Positive Activity on ER-Regulated Promoters in Endometrial Carcinoma Cells Endocrinology, February 1, 2005; 146(2): 751 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell Nutritional modulation of the cell cycle and breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 603 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Alao, E. W-F. Lam, S. Ali, L. Buluwela, W. Bordogna, P. Lockey, R. Varshochi, A. V. Stavropoulou, R. C. Coombes, and D. M. Vigushin Histone Deacetylase Inhibitor Trichostatin A Represses Estrogen Receptor {alpha}-Dependent Transcription and Promotes Proteasomal Degradation of Cyclin D1 in Human Breast Carcinoma Cell Lines Clin. Cancer Res., December 1, 2004; 10(23): 8094 - 8104. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. S. Miller, S. Suzuki, L. K. Miller, R. Handa, and R. M. Uht Estrogen Receptor (ER){beta} Isoforms Rather Than ER{alpha} Regulate Corticotropin-Releasing Hormone Promoter Activity through an Alternate Pathway J. Neurosci., November 24, 2004; 24(47): 10628 - 10635. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oh, H.-J. List, R. Reiter, A. Mani, Y. Zhang, E. Gehan, A. Wellstein, and A. T. Riegel The Nuclear Receptor Coactivator AIB1 Mediates Insulin-like Growth Factor I-induced Phenotypic Changes in Human Breast Cancer Cells Cancer Res., November 15, 2004; 64(22): 8299 - 8308. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Selva, O. M. Tirado, N. Toran, C. A. Suarez-Quian, J. Reventos, and F. Munell Estrogen Receptor {beta} Expression and Apoptosis of Spermatocytes of Mice Overexpressing a Rat Androgen-Binding Protein Transgene Biol Reprod, November 1, 2004; 71(5): 1461 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Bardin, N Boulle, G Lazennec, F Vignon, and P Pujol Loss of ER{beta} expression as a common step in estrogen-dependent tumor progression Endocr. Relat. Cancer, September 1, 2004; 11(3): 537 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cicatiello, R. Addeo, A. Sasso, L. Altucci, V. B. Petrizzi, R. Borgo, M. Cancemi, S. Caporali, S. Caristi, C. Scafoglio, et al. Estrogens and Progesterone Promote Persistent CCND1 Gene Activation during G1 by Inducing Transcriptional Derepression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) Complex Assembly to a Distal Regulatory Element and Recruitment of Cyclin D1 to Its Own Gene Promoter Mol. Cell. Biol., August 15, 2004; 24(16): 7260 - 7274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardin, P. Hoffmann, N. Boulle, D. Katsaros, F. Vignon, P. Pujol, and G. Lazennec Involvement of Estrogen Receptor {beta} in Ovarian Carcinogenesis Cancer Res., August 15, 2004; 64(16): 5861 - 5869. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Smith, S. R. Coats, H. Qin, M. S. Petrie, J. W. Covington, M. Su, M. Eren, and D. E. Vaughan Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor {alpha} and Estrogen Receptor {beta} in Endothelial Cells Circ. Res., August 6, 2004; 95(3): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Mueller, S. Simon, K. Chae, M. Metzler, and K. S. Korach Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor {alpha} (ER{alpha}) and ER{beta} in Human Cells Toxicol. Sci., July 1, 2004; 80(1): 14 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Yang, R. Liu, E. J. Perez, Y. Wen, S. M. Stevens Jr., T. Valencia, A.-M. Brun-Zinkernagel, L. Prokai, Y. Will, J. Dykens, et al. Mitochondrial localization of estrogen receptor {beta} PNAS, March 23, 2004; 101(12): 4130 - 4135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Waalkes, J. Liu, H. Chen, Y. Xie, W. E. Achanzar, Y.-S. Zhou, M.-L. Cheng, and B. A. Diwan Estrogen Signaling in Livers of Male Mice With Hepatocellular Carcinoma Induced by Exposure to Arsenic In Utero J Natl Cancer Inst, March 17, 2004; 96(6): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cheng, Z. Weihua, M. Warner, and J.-A. Gustafsson Inaugural Article: Estrogen receptors ER{alpha} and ER{beta} in proliferation in the rodent mammary gland PNAS, March 16, 2004; 101(11): 3739 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi, S. Borowicz, R. Pramanik, R. M. Schultz, J. Han, and G. Chen Estrogen Receptor Inhibits c-Jun-dependent Stress-induced Cell Death by Binding and Modifying c-Jun Activity in Human Breast Cancer Cells J. Biol. Chem., February 20, 2004; 279(8): 6769 - 6777. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strom, J. Hartman, J. S. Foster, S. Kietz, J. Wimalasena, and J.-A. Gustafsson Estrogen receptor {beta} inhibits 17{beta}-estradiol-stimulated proliferation of the breast cancer cell line T47D PNAS, February 10, 2004; 101(6): 1566 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paruthiyil, H. Parmar, V. Kerekatte, G. R. Cunha, G. L. Firestone, and D. C. Leitman Estrogen Receptor {beta} Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest Cancer Res., January 1, 2004; 64(1): 423 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng, B. K. C. Chow, and P. C. K. Leung An Activator Protein 1-Like Motif Mediates 17{beta}-Estradiol Repression of Gonadotropin-Releasing Hormone Receptor Promoter via an Estrogen Receptor {alpha}-Dependent Mechanism in Ovarian and Breast Cancer Cells Mol. Endocrinol., December 1, 2003; 17(12): 2613 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Geraldes, M. G. Sirois, and J.-F. Tanguay Specific Contribution of Estrogen Receptors on Mitogen-Activated Protein Kinase Pathways and Vascular Cell Activation Circ. Res., September 5, 2003; 93(5): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Watanabe, M. Akishita, T. Nakaoka, K. Kozaki, Y. Miyahara, H. He, Y. Ohike, T. Ogita, S. Inoue, M. Muramatsu, et al. Estrogen receptor {beta} mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation Cardiovasc Res, September 1, 2003; 59(3): 734 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Matthews and J.-A. Gustafsson Estrogen Signaling: A Subtle Balance Between ER{alpha} and ER{beta} Mol. Interv., August 1, 2003; 3(5): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marino, F. Acconcia, and A. Trentalance Biphasic Estradiol-induced AKT Phosphorylation Is Modulated by PTEN via MAP Kinase in HepG2 Cells Mol. Biol. Cell, June 1, 2003; 14(6): 2583 - 2591. |